We only have this paper's title and publication details.
Read it at the sourceImatinib resistance in GI stromal tumors (GISTs) is primarily caused by secondary
No takes yet. Share an insight, caveat, or question.
Mühlenberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: